Genetic and molecular diversity in nondeletion Hb H disease.
Author(s) -
Douglas R. Higgs,
L. Pressley,
B. Aldridge,
J. B. Clegg,
D. J. Weatherall,
Antonio Cao,
M. G. Hadjiminas,
C Kattamis,
A. MetaxatouMavromati,
E. A. Rachmilewitz,
T. Sophocleous
Publication year - 1981
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.78.9.5833
Subject(s) - haplotype , genetics , globin , biology , thalassemia , restriction enzyme , endonuclease , gene , alpha (finance) , genetic diversity , microbiology and biotechnology , alpha globulin , allele , medicine , population , construct validity , nursing , environmental health , patient satisfaction
Restriction endonuclease mapping of nondeletion alpha-thalassemia determinants from a variety of racial groups showed no detectable abnormalities within a 40-kilobase region of the zeta-alpha globin gene cluster. By using a zeta-specific probe, we defined three different types of interactions that give rise to Hb H disease, each involving a nondeletion alpha-thalassemia haplotype. mRNA analysis showed further diversity within these groups, indicating that there are at least three nondeletion determinations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom